Cleared Traditional

K201060 - Cordiana Dx16

K201060 is the FDA 510(k) clearance for Cordiana Dx16 by Cordiana Medical Informatics AG. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Traditional 510(k) pathway after a 209-day FDA review.

K201060 · Cordiana Medical Informatics AG · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
209d
Days
Class 2
Risk

K201060 is an FDA 510(k) clearance for the Cordiana Dx16. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Cordiana Medical Informatics AG (Root, CH). The FDA issued a Cleared decision on November 16, 2020 after a review of 209 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cordiana Medical Informatics AG devices

Submission Details

510(k) Number K201060 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2020
Decision Date November 16, 2020
Days to Decision 209 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d slower than avg
Panel avg: 125d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 246
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K201060.
AcQMap High Resolution Imaging and Mapping System
K201015 · Acutus Medical, Inc. · Dec 2020
CARTO® 3 EP Navigation System with Signal Processing Unit
K200484 · Biosense Webster, Inc. · Nov 2020
EnSite X EP System, Advisor VL Circular Mapping Catheter, Sensor Enabled, Advisor FL Circular Mapping Catheter, Sensor Enabled, Advisor HD Grid High Density Mapping Catheter, Senor Enabled
K202066 · Abbott Medical · Nov 2020
CoroFlow Cardiovascular System
K201881 · Coroventis Research AB · Nov 2020
KardiaAI
K201985 · AliveCor, Inc. · Nov 2020
HemoSphere Advanced Monitoring Platform, HemoSphere ClearSight Module
K201446 · Edwards Lifesiences, LLC · Oct 2020